PriceTracker GLP-1

The library, counted

Primary sources

391

distinct pages and records we cite

Program pages

48

seller pages behind the board, read weekly

Government records

94

FDA, CMS, Medicare, Medicaid and other agencies

Labels and trials

45

quoted for clinical statements

Program pages

48 sources

The seller's own pages behind every price on the board, plus the program pages we quote for states, terms and refunds. Pricing pages are read weekly; the date is our newest genuine read.

SourceLast read
Bodybuilding.com Health+ pricing, home pagebbhealthplus.com
bmiMD pricing, /compounded-semaglutidebmimd.com · cited 2 times
bmiMD pricing, /compounded-tirzepatidebmimd.com
CoreAge Rx pricing, /product/semaglutidecoreagerx.com
CoreAge Rx pricing, /product/tirzepatidecoreagerx.com
Direct Meds GLP-1 pricing, /solutions/weight-lossdirectmeds.com · cited 2 times
DudeMeds pricing, /weight-lossdudemeds.com
Enhance MD pricing, /product/advanced-tirzepatideenhance.md
Enhance MD pricing, /product/core-semaglutideenhance.md
Enhance MD pricing, /product/microdosing-tirzepatideenhance.md
Gala Health pricing, /weight-loss/compounded-glp1galaglp1.com · cited 2 times
Gala Health pricing, /weight-loss/ozempicgalaglp1.com
Gala Health pricing, home pagegalaglp1.com
Embody pricing, /products/compounded-semaglutide-glp-1-copyjoinem.co
Embody pricing, /products/compounded-semaglutide-glp-1-copy-1joinem.co
Embody pricing, /products/compounded-semaglutide-glp-1-copy-2joinem.co · cited 4 times
Embody pricing, /products/compounded-semaglutide-one-monthjoinem.co · cited 3 times
Embody pricing, /products/compounded-tirzepatide-glp-1-gip-copyjoinem.co · cited 3 times
Embody pricing, /products/compounded-tirzepatide-glp-1-gip-copy-1joinem.co
Embody pricing, /products/compounded-tirzepatide-glp-1-gip-copy-2joinem.co
Embody pricing, /products/compounded-tirzepatide-glp1-gip-one-month-supplyjoinem.co
Found pricing, /plans-and-pricingjoinfound.com
Found pricing, /store/compounded-semaglutidejoinfound.com
Found, homepagejoinfound.com
Sprout Health pricing, home pagejoinsprouthealth.com
MangoRx pricing, /products/slimmangorx.com
Oak Longevity pricing, /weightlossoaklovesyou.com
Sesame Care pricing, /service/online-weight-loss-programsesamecare.com · cited 2 times
SkinnyRx pricing, /products/semaglutide-injectableskinnyrx.com
SkinnyRx pricing, /products/semaglutide-tabletsskinnyrx.com
SkinnyRx pricing, /products/tirzepatide-injectableskinnyrx.com
SkinnyRx pricing, /products/tirzepatide-tabletsskinnyrx.com
SnagRx pricing, home pagesnagrx.com · cited 3 times
Willow pricing, /compound-semaglutidestartwillow.com
Willow pricing, /compound-tirzepatidestartwillow.com
Willow pricing, /semaglutide-tabletsstartwillow.com
Willow pricing, /tirzepatide-tabletsstartwillow.com
Strut Health pricing, /weight-loss/semaglutidestruthealth.com
TMates pricing, /products/semaglutidetmates.com
TMates pricing, /products/tirzepatidetmates.com
ShedRx pricing, /products/compounded-semaglutide-injectionstryshed.com
ShedRx pricing, /products/compounded-tirzepatide-injectionstryshed.com
Trimi pricing, /treatments/semaglutidetrytrimi.com
Trimi pricing, /treatments/tirzepatidetrytrimi.com
Trimi, availability by statetrytrimi.com
Trimi, FAQ: insurance and HSA/FSAtrytrimi.com
Trimi, homepage FAQ (billing plans, fees, charges, refunds)trytrimi.com · cited 2 times
Wellorithm pricing, /campaign-8wellorithm.com · cited 2 times

Manufacturers

47 sources

Eli Lilly and Novo Nordisk pages behind the self-pay dose ladders, savings cards and patient assistance rules.

SourceLast read
Eli Lilly, Foundayo Self-Pay Journey Program termsfoundayo.lilly.com · cited 7 times
Eli Lilly, lawsuits against retatrutide sellers (press release, August 12, 2026)investor.lilly.com
Eli Lilly, Lilly Employer Connect launch (5 March 2026)investor.lilly.com
Eli Lilly, TRIUMPH-1 topline results (press release, May 21, 2026)investor.lilly.com
Eli Lilly, TRIUMPH-4 topline results (press release, December 11, 2025)investor.lilly.com
Lilly, Zepbound self-pay terms and conditionslilly.com
LillyDirect FAQ: payment methodslilly.com
LillyDirect, Medicare GLP-1 Bridgelilly.com · cited 2 times
LillyDirect, Mounjaro self-pay purchase offer termslilly.com · cited 2 times
LillyDirect, Mounjaro self-pay, and Lilly pricing informationlilly.com · cited 12 times
LillyDirect, Zepbound Self Pay Journey Program purchase offer terms (single-dose vial and KwikPen)lilly.com · cited 10 times
LillyDirect, Zepbound self-pay (KwikPen and single-dose vial cards)lilly.com · cited 4 times
Lilly Cares Foundation, about the programmelillycares.com
Lilly Cares Foundation, available medicationslillycares.com · cited 2 times
Lilly Cares Foundation, how to applylillycares.com · cited 6 times
Lilly Medical (for US healthcare professionals), Is there an expanded access program for retatrutide?medical.lilly.com
Eli Lilly, Mounjaro savings card termsmounjaro.lilly.com · cited 10 times
Lilly, Mounjaro and the Medicare Prescription Payment Planmounjaro.lilly.com
Mounjaro.lilly.com, what Mounjaro is formounjaro.lilly.com · cited 7 times
Novo Nordisk PAP, available products list (PDF)novocare.com · cited 3 times
Novo Nordisk Patient Assistance Program, eligibilitynovocare.com · cited 5 times
NovoCare Pharmacy, Ozempic pill self-pay and savings terms (Novo Nordisk)novocare.com · cited 6 times
NovoCare Pharmacy, self-pay programme termsnovocare.com
NovoCare Pharmacy, Wegovy page: what Wegovy tablets are used for (Novo Nordisk)novocare.com · cited 2 times
NovoCare Pharmacy, Wegovy termsnovocare.com · cited 46 times
NovoCare, Ozempic list price explainednovocare.com
NovoCare, Ozempic pill and pen price guide (PDF, May 2026)novocare.com · cited 2 times
NovoCare, Ozempic savings offer and self-pay pricingnovocare.com · cited 9 times
NovoCare, Rybelsus page: the move to the Ozempic pill (Novo Nordisk)novocare.com · cited 5 times
NovoCare, Wegovy list price explainednovocare.com
NovoCare, Wegovy savings card termsnovocare.com · cited 10 times
Novo Nordisk, Capital Markets Day 2026, US Operations presentation (21 September 2026)novonordisk.com
Novo Nordisk, REIMAGINE 2 headline results in type 2 diabetes (company announcement, 2 February 2026)novonordisk.com
Novo Nordisk, Ozempic indicationozempic.com · cited 9 times
Ozempic.com, cost and coverageozempic.com
Eli Lilly, Zepbound cost informationpricinginfo.lilly.com · cited 27 times
Lilly, Mounjaro pricing informationpricinginfo.lilly.com · cited 11 times
RYBELSUS.com, uses and how to take it (Novo Nordisk)rybelsus.com
Lilly Trials, TRIUMPH-5 study page (retatrutide compared to tirzepatide)trials.lilly.com
Novo Nordisk, the Medicare GLP-1 Bridge and Wegovywegovy.com · cited 5 times
Wegovy.com, cost and coveragewegovy.com · cited 2 times
Wegovy.com, the tabletwegovy.com · cited 8 times
Eli Lilly, the Medicare GLP-1 Bridge and Zepboundzepbound.lilly.com
Eli Lilly, Zepbound KwikPen self-pay terms (manufacturer context)zepbound.lilly.com
Eli Lilly, Zepbound savings program termszepbound.lilly.com
Lilly, Zepbound savings page: HSA/FSA notezepbound.lilly.com
Zepbound.lilly.com, dosingzepbound.lilly.com · cited 2 times

U.S. Food and Drug Administration

42 sources

Approvals, warning letters, the 503B outsourcing register, the shortage list, recalls, the NDC directory and compounding policy.

SourceLast read
Drugs@FDA, Mounjaro (NDA 215866) approval historyaccessdata.fda.gov
FDA drug shortage databaseaccessdata.fda.gov · cited 2 timesNot stored
FDA drug shortage databaseaccessdata.fda.gov · cited 2 timesNot stored
FDA Orange Book, Ozempic (NDA 209637) patent and exclusivity listingaccessdata.fda.gov · cited 2 times
FDA Orange Book, patent and exclusivity listing for Mounjaro (NDA 215866)accessdata.fda.gov
FDA Orange Book, patent and exclusivity listing for Zepbound (NDA 217806)accessdata.fda.gov · cited 3 times
FDA Orange Book, product details for Mounjaro (NDA 215866)accessdata.fda.gov
FDA Orange Book, Rybelsus (NDA 213051) patent listingaccessdata.fda.gov
FDA Orange Book, Wegovy (NDA 215256) patent and exclusivity listingaccessdata.fda.gov
FDA, drug shortage databaseaccessdata.fda.gov
FDA, enforcement reports (recalls)accessdata.fda.gov
GATTEX (teduglutide) prescribing information, FDAaccessdata.fda.gov
FDA National Drug Code directory (openFDA), oral semaglutide tablet listings: RYBELSUS 3, 7 and 14 mg from 20 September 2019; WEGOVY 1.5, 4, 9 and 25 mg from 6 January 2026; OZEMPIC 1.5, 4 and 9 mg from 27 April 2026api.fda.gov
FDA National Drug Code directory (openFDA), semaglutide listings: strengths and marketing start datesapi.fda.gov
FDA National Drug Code directory, oral semaglutide listingsapi.fda.gov · cited 2 times
FDA press announcementfda.gov · cited 3 times
FDA press release, Zepbound approvalfda.gov
FDA warning letter to GLP-1 Solution, 9 September 2025fda.gov
FDA warning letter to Hims & Hers Health, Inc. dba Hers, MARCS-CMS 716825, 9 September 2025fda.gov
FDA warning letter to Hims & Hers Health, Inc. dba Hims, MARCS-CMS 716567, 9 September 2025fda.gov · cited 2 times
FDA warning letters database, search for "Henry Meds" (no letters returned on 2026-10-05)fda.gov
FDA warning letters database, search for "Noom" (no letters returned on 2026-10-05)fda.gov
FDA warning-letter database, searched for "Calibrate Health" (no letter listed on 5 Oct 2026; our own FDA letter file holds none either)fda.gov
FDA warning-letter database, searched for "LifeMD" (no letter listed on 5 Oct 2026; our own FDA letter file holds none either)fda.gov
FDA warning-letter database, searched for "Mochi Health" (no letter listed on 5 Oct 2026; our own FDA letter file holds none either)fda.gov
FDA, About Warning and Close-Out Lettersfda.gov · cited 2 times
FDA, compounder policy update on GLP-1 supplyfda.gov · cited 25 times
FDA, Compounding and the FDA: Questions and Answersfda.gov · cited 12 times
FDA, concerns with unapproved GLP-1 drugs used for weight lossfda.gov · cited 16 times
FDA, concerns with unapproved GLP-1 drugs used for weight lossfda.gov · cited 4 times
FDA, first generic of a once-daily GLP-1 injection (liraglutide, 23 December 2024)fda.gov
FDA, Form 483 Frequently Asked Questionsfda.gov
FDA, Frequently Asked Questions on Patents and Exclusivityfda.gov
FDA, Generic Drug Factsfda.gov
FDA, Generic Drugs: Questions & Answersfda.gov
FDA, National Drug Code Directoryfda.gov
FDA, PDUFA reauthorization performance goals and procedures, fiscal years 2023 through 2027fda.gov
FDA, Personal Importationfda.gov · cited 2 times
FDA, press release of 3 March 2026: 30 warning letters to telehealth companies over compounded GLP-1 marketingfda.gov
FDA, proposal to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks listfda.gov · cited 10 times
FDA, Registered Outsourcing Facilities (503B), updated September 30, 2026fda.gov · cited 4 times
FDA, Warning Letters index (searched for semaglutide, tirzepatide, liraglutide, retatrutide, GLP-1)fda.gov · cited 3 times

Drug labels, trials and journals

45 sources

DailyMed prescribing information, ClinicalTrials.gov records and published trials, quoted for every clinical statement.

SourceLast read
American College of Cardiology on SURMOUNT-5 (tirzepatide vs semaglutide, head to head)acc.org · cited 9 times
ClinicalTrials.gov API, status and primary completion dates of the TRIUMPH phase 3 trialsclinicaltrials.gov
ClinicalTrials.gov NCT05822830, SURMOUNT-5 designclinicaltrials.gov · cited 2 times
ClinicalTrials.gov, NCT07092605, the registry record (status: enrolling by invitation)clinicaltrials.gov
FDA label for Wegovy (semaglutide), via DailyMed: section 2.1, and the Instructions for Use for the pen and for the single-dose prefilled syringedailymed.nlm.nih.gov · cited 6 times
FDA label for Zepbound (tirzepatide), via DailyMeddailymed.nlm.nih.gov · cited 2 times
Foundayo prescribing information (DailyMed)dailymed.nlm.nih.gov · cited 3 times
Mounjaro prescribing information (DailyMed), sections 2.1 and 2.2dailymed.nlm.nih.gov · cited 3 times
Ozempic prescribing information (DailyMed)dailymed.nlm.nih.gov · cited 17 times
Rybelsus and Ozempic tablets prescribing information (DailyMed), sections 2.1 to 2.4dailymed.nlm.nih.gov · cited 2 times
Trulicity prescribing information (DailyMed), sections 1 and 12.1dailymed.nlm.nih.gov
Wegovy prescribing information (DailyMed)dailymed.nlm.nih.gov · cited 30 times
Zepbound prescribing information (DailyMed), indications and dosingdailymed.nlm.nih.gov · cited 42 times
NHLBI, Sleep apneanhlbi.nih.gov
NIDDK, NAFLD and NASHniddk.nih.gov
Ozempic prescribing information, section 2.2 Recommended Dosage (Novo Nordisk, revised 05/2026)novo-pi.com · cited 10 times
Wegovy prescribing information, maintenance dosagenovo-pi.com · cited 5 times
Mounjaro prescribing informationpi.lilly.com · cited 24 times
Zepbound prescribing information, sections 1 and 6.1 (the same molecule in weight-loss trials)pi.lilly.com · cited 4 times
The joint Advisory, full text (Obesity Pillars 2025, open access), managing nausea and vomitingpmc.ncbi.nlm.nih.gov · cited 8 times
Aronne et al., SURMOUNT-4, JAMA 2024, trial entry criteriapubmed.ncbi.nlm.nih.gov · cited 3 times
Aronne et al., SURMOUNT-5, N Engl J Med 2025;393:26-36pubmed.ncbi.nlm.nih.gov
Aronne et al., Tirzepatide as Compared with Semaglutide for the Treatment of Obesity, N Engl J Med 2025;393:26-36 (SURMOUNT-5)pubmed.ncbi.nlm.nih.gov · cited 8 times
Bellido et al., Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2), The Lancet, September 29, 2026 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
Jastreboff et al., Retatrutide, a Triple Hormone Receptor Agonist, for Treatment of Obesity (TRIUMPH-1), N Engl J Med, September 29, 2026 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
Jastreboff et al., SURMOUNT-1, NEJM 2022pubmed.ncbi.nlm.nih.gov · cited 6 times
Jastreboff et al., Triple-Hormone-Receptor Agonist Retatrutide for Obesity, a Phase 2 Trial, N Engl J Med 2023;389:514-526 (PubMed abstract)pubmed.ncbi.nlm.nih.gov · cited 2 times
Leech et al., PubMed 21782840pubmed.ncbi.nlm.nih.gov · cited 2 times
Malhotra A, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). N Engl J Med 2024; abstract on PubMedpubmed.ncbi.nlm.nih.gov · cited 2 times
Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory (ACLM, ASN, OMA, TOS). Am J Clin Nutr 2025; abstract on PubMedpubmed.ncbi.nlm.nih.gov
Nauck and Meier, PubMed 34310013pubmed.ncbi.nlm.nih.gov · cited 2 times
OASIS 4, N Engl J Med 2025;393:1077-1087 (PubMed abstract)pubmed.ncbi.nlm.nih.gov · cited 2 times
PIONEER 1, Aroda et al., Diabetes Care 2019;42:1724-1732 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
REDEFINE 1, Garvey et al., N Engl J Med 2025;393:635-647 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
REDEFINE 2, Davies et al., N Engl J Med 2025;393:648-659 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
REDEFINE 3 design paper, Cavender et al., Am Heart J, published online 6 October 2026 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
REDEFINE 5, Yamauchi et al., Lancet Diabetes Endocrinol 2026;14:450-462 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
Rubino D, et al. STEP 4 randomized clinical trial. JAMA 2021; abstract on PubMedpubmed.ncbi.nlm.nih.gov
STEP UP trial, once-weekly semaglutide 7.2 mg in adults with obesity, Lancet Diabetes Endocrinol 2025 (PubMed 40961952)pubmed.ncbi.nlm.nih.gov · cited 2 times
STEP UP trial, serious adverse events (PubMed search result snippet)pubmed.ncbi.nlm.nih.gov
SURPASS-1, Rosenstock et al., Lancet 2021;398:143-155 (PubMed abstract)pubmed.ncbi.nlm.nih.gov
SURPASS-2, Frías et al., N Engl J Med 2021;385:503-515 (PubMed abstract)pubmed.ncbi.nlm.nih.gov · cited 2 times
Wharton et al., ATTAIN-1, N Engl J Med 2025 (PubMed 40960239)pubmed.ncbi.nlm.nih.gov
Wilding et al., Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1), N Engl J Med 2021 (PubMed abstract)pubmed.ncbi.nlm.nih.gov · cited 3 times
Wilding et al., Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension, Diabetes Obes Metab 2022pubmed.ncbi.nlm.nih.gov · cited 2 times

CMS, Medicare, Medicaid and other government sources

52 sources

Medicare and Medicaid rules and spending data, NADAC pharmacy costs, poverty guidelines and other public records.

SourceLast read
HHS, 2026 poverty guidelines (48 contiguous states and DC)aspe.hhs.gov
State of Connecticut Care Compass, weight managementcarecompass.ct.gov
CMS, Medicare GLP-1 Bridge (what it is, how it pays)cms.gov · cited 5 times
FTC Consumer Advice, The Truth Behind Weight Loss Adsconsumer.ftc.gov
CMS, Medicare Part D Spending by Drug, data year 2024 (data.cms.gov), updated June 25, 2026data.cms.gov
CMS, the same dataset as CSVdata.cms.gov
CMS, National Average Drug Acquisition Cost (NADAC)data.medicaid.gov
CMS, State Drug Utilization Data 2025 (data.medicaid.gov), updated July 13, 2026data.medicaid.gov · cited 2 times
Colorado Department of Personnel and Administration, GLP-1s for weight loss coverage change 2026 (FAQ)dhr.colorado.gov
California Franchise Tax Board, 2025 Form FTB 3805P instructionsftb.ca.gov
FTC, Gut Check: A Reference Guide for Media on Spotting False Weight Loss Claimsftc.gov
E.D. Pa., MDL 3094, Memorandum of 17 October 2024 (GovInfo)govinfo.gov
E.D. Pa., MDL 3094, Memorandum on Cross Cutting Issue No. 1 (15 August 2025, GovInfo)govinfo.gov · cited 2 times
E.D. Pa., MDL 3094, Memorandum on the motion to dismiss the Master Complaint (15 August 2025, GovInfo)govinfo.gov
E.D. Pa., MDL 3094, Order of 17 October 2024 on marketing discovery (GovInfo)govinfo.gov
Judicial Panel on Multidistrict Litigation, Transfer Order, MDL No. 3094 (GovInfo)govinfo.gov · cited 2 times
HealthCare.gov glossaryhealthcare.gov
HealthCare.gov glossary, formularyhealthcare.gov
IRS newsroom, tax year 2026 inflation adjustments (IR-2025-103): health FSA limit, carryover, 22% bracketirs.gov
IRS Publication 502, Medical and Dental Expenses: Medicinesirs.gov · cited 6 times
IRS Publication 969: who can contribute to an HSAirs.gov · cited 8 times
IRS Topic no. 751, Social Security and Medicare withholding ratesirs.gov
IRS, FAQs about medical expenses related to nutrition, wellness and general health (Q9, Q10, Q13, Q14)irs.gov
Massachusetts Group Insurance Commission, June 2026 update on GLP-1 coveragemass.gov
CMS, State Drug Utilization Data: about the datamedicaid.gov · cited 2 times
Medicaid.gov, NADACmedicaid.gov
Medicare.gov, drug plan coverage rulesmedicare.gov
Medicare.gov, Part D deductible and out-of-pocket cap, 2026 and 2027medicare.gov
Medicare.gov, weight loss drugs (Medicare GLP-1 Bridge)medicare.gov · cited 25 times
North Carolina Department of State Treasurer, State Health Plan GLP-1 exclusion (22 April 2024)nctreasurer.gov
E.D. Pa., MDL 3094, Case Management Order No. 20 (25 October 2024), footnote 1paed.uscourts.gov
E.D. Pa., MDL 3094, Case Management Order No. 32 (30 April 2026)paed.uscourts.gov
U.S. District Court, E.D. Pa., MDL 3094 orders list (page 2)paed.uscourts.gov
U.S. District Court, E.D. Pa., MDL 3094 page (About)paed.uscourts.gov · cited 3 times
U.S. District Court, E.D. Pa., MDL 3163 page (NAION)paed.uscourts.gov
Novo Nordisk, financial report for H1 2026 (Form 6-K, SEC)sec.gov
CVS Caremark, formulary change communicated to plan memberssehp.healthbenefitsprogram.ks.gov · cited 2 times
Kansas State Employee Health Plan, GLP-1ssehp.healthbenefitsprogram.ks.gov
TrumpRx.gov, browse page (Presidential deals)trumprx.gov
TrumpRx.gov, Foundayo pagetrumprx.gov
TrumpRx.gov, generic liraglutide pagetrumprx.gov
TrumpRx.gov, Mounjaro pagetrumprx.gov
TrumpRx.gov, Ozempic pen pagetrumprx.gov
TrumpRx.gov, Ozempic pill pagetrumprx.gov
TrumpRx.gov, Trulicity pagetrumprx.gov
TrumpRx.gov, Wegovy pen page (offer text and terms)trumprx.gov
TrumpRx.gov, Wegovy pill pagetrumprx.gov
TrumpRx.gov, Zepbound KwikPen pagetrumprx.gov
TrumpRx.gov, Zepbound vial pagetrumprx.gov
White House fact sheet, Lilly and Novo Nordisk agreements (6 November 2025)whitehouse.gov
White House fact sheet, TrumpRx.gov generics expansion (18 May 2026)whitehouse.gov
White House fact sheet, TrumpRx.gov launch (5 February 2026)whitehouse.gov

KFF and health policy research

5 sources

Independent research on coverage and cost, quoted where a federal source does not answer the question.

Insurers and pharmacy benefit managers

62 sources

Formularies, prior authorization policies and coverage statements behind every insurer answer.

SourceLast read
Aetna, Ozempic prior authorisation policyaetna.com · cited 8 times
Aetna, weight-loss GLP-1 prior authorisation policyaetna.com
Aetna: aetna.comaetna.com · cited 5 times
Aetna: aetna.comaetna.com · cited 18 times
Aetna: aetna.comaetna.com · cited 3 times
Aetna: aetna.comaetna.com · cited 4 times
CVS Caremark: aetna.comaetna.com
CVS Caremark: aetna.comaetna.com · cited 4 times
Ambetter (Centene): ambetterhealth.comambetterhealth.com · cited 6 times
Ambetter (Centene): ambetterhealth.comambetterhealth.com · cited 4 times
Ambetter (Centene): ambetterhealth.comambetterhealth.com · cited 2 times
Ambetter (Centene): ambetterhealth.comambetterhealth.com · cited 8 times
Florida Blue: bcbsfl.combcbsfl.com · cited 4 times
Blue Cross Blue Shield of Michigan, why it is changing GLP-1 weight-loss coverage (2024, revised May 2025)bcbsm.mibluedaily.com · cited 3 times
Blue Cross Blue Shield of Massachusetts, GLP-1 coverage updatebluecrossma.org
Anthem: carelonrx.comcarelonrx.com · cited 4 times
CVS Caremark: caremark.comcaremark.com · cited 4 times
CVS Caremark: caremark.comcaremark.com · cited 2 times
FEP Blue (Federal Employee Program): caremark.comcaremark.com · cited 3 times
FEP Blue (Federal Employee Program): caremark.comcaremark.com
Blue Cross Blue Shield: cbsnews.comcbsnews.com
CVS Health, Zepbound returning to commercial formulariescvshealth.com · cited 11 times
Cigna: evernorth.comevernorth.com · cited 5 times
Evernorth (Express Scripts), EncircleRx GLP-1 program for employers and health plansevernorth.com
Cigna: express-scripts.comexpress-scripts.com · cited 8 times
Express Scripts: express-scripts.comexpress-scripts.com · cited 10 times
Express Scripts: express-scripts.comexpress-scripts.com
Blue Cross Blue Shield Federal Employee Program, Zepbound policyfepblue.org · cited 5 times
Blue Cross Blue Shield: fepblue.orgfepblue.org · cited 4 times
FEP Blue (Federal Employee Program): fepblue.orgfepblue.org
Aetna: fm.formularynavigator.comfm.formularynavigator.com · cited 18 times
Anthem, 2026 New York Essential 3-Tier drug listfm.formularynavigator.com · cited 11 times
Cigna: healthcaredive.comhealthcaredive.com · cited 5 times
Kaiser Permanente: healthy.kaiserpermanente.orghealthy.kaiserpermanente.org · cited 4 times
Kaiser Permanente: healthy.kaiserpermanente.orghealthy.kaiserpermanente.org · cited 3 times
Humana, does Medicare cover weight loss drugshumana.com · cited 15 times
Medi-Cal: medi-calrx.dhcs.ca.govmedi-calrx.dhcs.ca.gov · cited 11 times
Molina Healthcare: molinamarketplace.commolinamarketplace.com · cited 6 times
Molina Healthcare: molinamarketplace.commolinamarketplace.com · cited 10 times
TRICARE: newsroom.tricare.milnewsroom.tricare.mil · cited 2 times
Aetna: novocare.comnovocare.com · cited 2 times
NovoCare, Wegovy savings offer and self-pay pricingnovocare.com · cited 10 times
Aetna: novomedlink.comnovomedlink.com
FEHB (federal employees): opm.govopm.gov · cited 4 times
FEHB (federal employees): opm.govopm.gov · cited 8 times
FEHB (federal employees): opm.govopm.gov · cited 2 times
FEHB (federal employees): opm.govopm.gov · cited 2 times
Blue Cross Blue Shield: providerinfo.bcbsm.comproviderinfo.bcbsm.com · cited 2 times
Highmark: securecms.highmark.comsecurecms.highmark.com · cited 6 times
Cigna, GLP-1 weight-loss coverage policy (IP0621)static.cigna.com · cited 2 times
Cigna, Wegovy injection weight-loss coverage policy (IP0814, effective 1 September 2026)static.cigna.com · cited 7 times
Cigna: static.cigna.comstatic.cigna.com · cited 4 times
Cigna: static.cigna.comstatic.cigna.com · cited 8 times
Express Scripts: static.cigna.comstatic.cigna.com · cited 6 times
Express Scripts: static.cigna.comstatic.cigna.com · cited 6 times
Express Scripts: static.cigna.comstatic.cigna.com · cited 8 times
TRICARE: tricare.miltricare.mil · cited 8 times
Optum Rx: uhcprovider.comuhcprovider.com · cited 6 times
UnitedHealthcare, weight-loss prior authorisation programmeuhcprovider.com · cited 32 times
UnitedHealthcare: uhcprovider.comuhcprovider.com · cited 14 times
UnitedHealthcare: uhcprovider.comuhcprovider.com
Eli Lilly, Zepbound KwikPen purchase offer termszepbound.lilly.com · cited 17 times

Other sources

90 sources

Pharmacy price checkers, review platforms, certifiers and reporting we quote for a specific fact.

SourceLast read
AJMC, 5 things to know about retatrutide (August 14, 2026)ajmc.com
AJMC, retatrutide phase 3 TRIUMPH-1 topline results (21 May 2026)ajmc.com
Apotex news release, first US FDA tentative approval for generic semaglutide injection (10 April 2026)apotex.com
Becker's Payer Issues, 25 July 2023, University of Texas System and Ascensionbeckerspayer.com
BioPharma APAC, semaglutide generics six months in: India and China (8 October 2026)biopharmaapac.com
BioSpace, Lilly and FDA dispute over whether retatrutide is a biologic (August 5, 2026)biospace.com
International Foundation of Employee Benefit Plans, GLP-1 Drugs 2026 survey reportblog.ifebp.org
Business Group on Health, 2026 GLP-1 survey press release (105 employers, February to March 2026)businessgrouphealth.org
Business Group on Health, 2027 Employer Healthcare Strategy Survey press release (25 August 2026; 127 large employers, fielded June 2026)businessgrouphealth.org
Business Group on Health, how employers are managing GLP-1 coverage (2027 survey findings)businessgrouphealth.org
Health Canada, first generic semaglutide approved (28 April 2026)canada.ca
Health Canada, first generic semaglutide for weight loss (29 June 2026)canada.ca · cited 2 times
Health Canada, second generic semaglutide approved (1 May 2026)canada.ca
Cedars-Sinai, Dr Amanda Velazquez, Director of Obesity Medicinecedars-sinai.org
CNBC, 26 June 2026, on Mercer's 2026 findings and employer eligibility rulescnbc.com
CNBC, India launches generic semaglutide (23 March 2026)cnbc.com · cited 2 times
American Diabetes Association, REDEFINE 1 and 2 presented at the 85th Scientific Sessions (press release, 22 June 2025)diabetes.org
Drugs.com Foundayo monograph (medically reviewed)drugs.com
Drugs.com, Do GLP-1 patches work? (medically reviewed by Kristianne Hannemann, PharmD; updated 30 April 2026)drugs.com
Congressional Research Service, TrumpRx: Background and Implementation, IF13281 (31 July 2026)everycrsreport.com
Embody, offer page FAQ (states, pricing, cancellation, refunds)exclusive.joinem.co · cited 2 times
Fierce Pharma on the list pricefiercepharma.com
Reuters (via Yahoo Finance), Brazil approves first semaglutide pen after Ozempic patent expiry (26 May 2026)finance.yahoo.com
Financial Times, 1 May 2026, PwC limits US GLP-1 coverage to diabetesft.com
GATTEX, patient site (indication)gattex.com
Novo Nordisk, REDEFINE 1 headline results (company announcement, GlobeNewswire, 20 December 2024)globenewswire.com
Novo Nordisk, REDEFINE 2 headline results (company announcement, GlobeNewswire, 10 March 2025)globenewswire.com
Novo Nordisk, REDEFINE 4 headline results, CagriSema vs tirzepatide (company announcement, GlobeNewswire, 23 February 2026)globenewswire.com
Novo Nordisk, REIMAGINE 5 and REDEFINE 9 topline results (GlobeNewswire, 21 September 2026)globenewswire.com
GoodRx, Ozempic price pagegoodrx.com
GoodRx, Wegovy price pagegoodrx.com
Anvisa (Brazil's health regulator), Ozivy registration (27 May 2026)gov.br
Harvard Pilgrim Health Care, 2026 drug coverage updates (September 2025)harvardpilgrim.org
HealthEquity (an HSA and FSA administrator), GLP-1 eligibility page: FSA documentationhealthequity.com
Henry Meds FAQ (insurance, fees, delivery time)henrymeds.com
Henry Meds Programs: plan prices and what each includes (page dated December 3, 2025)henrymeds.com
Henry Meds, GLP-1 weight management page (starting price, pharmacies, eligibility, cancellation)henrymeds.com
Hims, Wegovy pill page: treatment comparison and FAQhims.com
Hims, weight loss FAQ: membership cost, cancellation and dose pricinghims.com
Hims, weight loss treatments and the membership termshims.com · cited 3 times
Hims, weight-loss membership page: what is included and cancellinghims.com
University of Iowa, UI GLP-1 Pilot Programhr.uiowa.edu
International Foundation of Employee Benefit Plans, GLP-1 Drugs: 2026 Pulse Survey (U.S.), eligibility rulesifebp.org
Calibrate, insurance page: brand-name drugs, self-pay, government coveragejoincalibrate.com · cited 2 times
Calibrate, pricingjoincalibrate.com · cited 4 times
Mochi Health, FAQ: membership prices and compounded medication pricesjoinmochi.com · cited 2 times
Mochi Health, homepage: medication menu and starting pricesjoinmochi.com · cited 2 times
Mochi Health, weight-loss page: how a prescription is filledjoinmochi.com
21 CFR 314.105(d), tentative approval of an ANDA (Cornell LII)law.cornell.edu
35 U.S.C. 271(a), patent infringement (Cornell LII)law.cornell.edu
LegitScript checker entry for joincalibrate.com, linked from the "LegitScript approved" seal (seal 6468398, served by LegitScript) on Calibrate's homepage; the checker is behind a captcha, so we could not read the status itselflegitscript.com
LegitScript checker entry for lifemd.com, linked from the LegitScript seal (seal 10012446, served by LegitScript) on LifeMD's pages; the checker is behind a captcha, so we could not read the status itselflegitscript.com
LegitScript, Healthcare Certificationlegitscript.com
LifeMD, weight management: program pricelifemd.com · cited 4 times
Mass General Brigham Health Plan, GLP-1 coveragemassgeneralbrighamhealthplan.org
Mercer, National Survey of Employer-Sponsored Health Plans 2025 (employers with 500 or more employees)mercer.com
NBC News on the KFF analysis of TrumpRx prices (7 October 2026)nbcnews.com
Noom Med overview: clinicians and brand-name accessnoom.com
Noom support FAQ, Noom GLP-1Rx Plus Program (compounded tirzepatide)noom.com
Noom, GLP-1 access and transparency (pharmacies and ingredient sourcing)noom.com
Noom, Microdose GLP-1Rx Program pagenoom.com
Noom, Noom GLP-1Rx Program page (price, footnote, FAQ, eligibility)noom.com
The Ohio State University Health Plan, weight managementosuhealthplan.com
Eli Lilly press release, agreement with the U.S. government (6 November 2025)prnewswire.com
Eli Lilly press release, Foundayo available in the US (9 April 2026)prnewswire.com
Eli Lilly, ATTAIN-1 results releaseprnewswire.com · cited 2 times
Eli Lilly, FDA approval announcementprnewswire.com · cited 17 times
Eli Lilly, TRIUMPH-1 full results and TRANSCEND-T2D-1 at ADA (press release, June 6, 2026)prnewswire.com
Eli Lilly, TRIUMPH-2 and TRIUMPH-3 topline results and filing plan (press release, July 23, 2026)prnewswire.com · cited 2 times
Eli Lilly, TRIUMPH-2 full results at EASD (press release, September 29, 2026)prnewswire.com
Goodpath, direct-to-employer Wegovy access with Novo Nordisk (18 February 2026)prnewswire.com
Novo Nordisk, FDA submission of CagriSema (press release, PR Newswire, 18 December 2025)prnewswire.com
Reuters, 11 June 2026, on the Mercer and Business Group on Health 2026 surveysreuters.com
Reuters, 2 June 2026, Cigna ends GLP-1 weight-loss coverage in its own employee planreuters.com
Ro pricing page (list price framing)ro.co · cited 4 times
Sandoz media release, generic semaglutide approved in Canada (18 September 2026)sandoz.com
STAT, 18 December 2025, HCA Healthcare ends Zepbound and Wegovy coverage for 2026statnews.com
Trustpilot, Calibrate profiletrustpilot.com
Trustpilot, Embody (joinem.co): 3.8 from 9,145 reviews when readtrustpilot.com · cited 2 times
Trustpilot, Henry Meds (henrymeds.com) company profile: score, review count, labelstrustpilot.com
Trustpilot, Hims (hims.com) company profile: score, review count, labelstrustpilot.com · cited 2 times
Trustpilot, LifeMD profiletrustpilot.com
Trustpilot, Mochi Health profiletrustpilot.com
Trustpilot, Noom (noom.com) company profile: score, review count, labelstrustpilot.com
Trustpilot, Ro (ro.co): 4.0 from 6,932 reviews when read; the profile covers all of Ro's servicestrustpilot.com
Trustpilot, SnagRx (snagrx.com): 8 reviews when read, below the 25 we need to print a scoretrustpilot.com
Trustpilot, Trimi Health (trytrimi.com): no rating shown when readtrustpilot.com
UnitedHealth Group, Optum Rx Weight Engage launchunitedhealthgroup.com
WeightWatchers, weight-loss medication programmeweightwatchers.com
West Virginia Public Broadcasting, PEIA pauses its GLP-1 pilotwvpublic.org

Found a source that says something else?

Send us the page. We re-read it, correct what needs correcting and date the fix on the corrections log.

Corrections log